Company type
Developer of personalized cancer treatments.Funding rounds
Series B USD 27,400,000
USD 27,400,000 ( )
Funding to expand the availability of its CANScript service, which predicts personalised responses to cancer treatments. Part of the proceeds were used to cash out Series A backers Karnataka Information Technology Venture Capital Fund and India Innovation
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Sands Capital Ventures LLC | Led the round. | ||
|
Sequoia Capital India | Led the round. | ||
|
RA Capital Management | Initial investment. | ||
|
Accel Partners & Co Inc | Early and growth stage venture capital firm. | Follow-on investment. | |
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Tata Capital Innovations Fund | Follow-on investment. |
Investment activity status
Active investor